Webinar Replays
Explore research findings and methodologies with teams that use our AO retinal imaging devices

Adressing a major unmet need for validating novel treatments for RP: biomarkers that are sensitive enough to the slowly progressing disease.

CKD, cardiovascular risks, cognitive decline. Micron-precision vascular assessments open new avenues for clinical research.

2 ophthalmology professors explain how they use the rtx1 AO camera to assess AMD at the cellular scale

2024 edition : 7 clinical research teams share insights obtained with rtx1 AO retinal camera, and discuss about standardization of AO studies

Interview of 3 ophthalmologists on how upcoming new features on rtx1 allow assessing RPE cells and flicker-induced vessel response with fast workflows

Interview & discussion with 3 ophthalmologists, first users of rtx1 with TFI optional module, about imaging RPE cells and pigment changes.

Novel findings in IRDs, AMD, HTA and MS, and methods for AO imaging, presented by 8 clinical centers.

Interview & discussion with 3 ophthalmology professors about the use of AO retinal imaging in dry AMD.

Discussion with 3 clinical experts on AO retinal imaging for diseases that alter small blood vessels.

30min roundtable discussion with 3 clinical experts on the use of AO retinal imaging in inherited retinal diseases.



Exciting news from the Lions Eye Institute in Perth, Australia!
Cone photoreceptor analysis got faster, more objective, and scalable
Celebrating 2025 milestones with our community
Introducing AObox: AI-Powered Cone Analysis for rtx1
Imagine Eyes installs a breakthrough cellular-resolution retinal tomograph at Emory University
Euretina highlights versatility of AO retinal assessments